Dupilumab Treatment Effective for Chronic Rhinosinusitis with Nasal Polyps - HCPLive
Dupilumab therapy over 3 years significantly improves chronic rhinosinusitis with nasal polyps (CRSwNP) symptoms, disease-related impairment, nasal polyp burden, and olfactory function, according to a multicenter, retrospective analysis involving 150 adult patients. The study, led by Patrick Huber, found sustained effectiveness by the 36-month mark, with 76.5% of subjects showing an 'excellent' treatment response. Adverse events were mostly self-limiting.
Highlighted Terms
Related News
Dupilumab therapy over 3 years significantly improves chronic rhinosinusitis with nasal polyps (CRSwNP) symptoms, disease-related impairment, nasal polyp burden, and olfactory function, according to a multicenter, retrospective analysis involving 150 adult patients. The study, led by Patrick Huber, found sustained effectiveness by the 36-month mark, with 76.5% of subjects showing an 'excellent' treatment response. Adverse events were mostly self-limiting.